Stock Rich List
#9208 on the rich list of 14,644 insiders

Scott L. Burrows

Chief Financial Officer at Spyre Therapeutics; Chief Financial Officer at Arcutis Biotherapeutics. Based in Waltham, Massachusetts.

$9.4M
in disclosed stock, −$331K (−3.41%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
9208th of 14,644
Companies held
2
Largest holding
SYRE, 82.9% of total
Latest SEC filing
Oct 1, 2026

What the $9.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Spyre Therapeutics SYRE
Common Stock
Directly79,762$97.63$7.8M82.9%Form 4, Oct 1, 2026
Arcutis Biotherapeutics ARQT
Common Stock
Directly59,115$27.17$1.6M17.1%Form 4, Mar 6, 2023

Share counts are the amounts Scott L. Burrows reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 1, 2026SoldSYRE600$89.07$53KView
Oct 1, 2026SoldSYRE1,500$90.27$135KView
Oct 1, 2026SoldSYRE2,100$91.92$193KView
Oct 1, 2026SoldSYRE3,071$92.95$285KView
Oct 1, 2026SoldSYRE229$93.57$21KView
Sep 30, 2026SoldSYRE17,500$89.89$1.6MView
Sep 2, 2026SoldSYRE18,232$89.35$1.6MView
Sep 1, 2026SoldSYRE200$89.04$18KView
Sep 1, 2026SoldSYRE2,016$88.03$177KView
Sep 1, 2026SoldSYRE900$86.25$78KView
Sep 1, 2026SoldSYRE4,384$87.11$382KView
Aug 3, 2026SoldSYRE2,300$96.30$221KView
Aug 3, 2026SoldSYRE5,100$95.21$486KView
Aug 3, 2026SoldSYRE100$97.10$10KView
Jul 1, 2026SoldSYRE5,775$87.55$506KView
Jul 1, 2026SoldSYRE1,725$88.37$152KView
Jun 25, 2026SoldSYRE5,000$87.12$436KView
Jun 25, 2026SoldSYRE10,000$87.14$871KView
Jun 1, 2026SoldSYRE3,100$72.06$223KView
Jun 1, 2026SoldSYRE2,599$70.77$184KView
Jun 1, 2026SoldSYRE1,801$69.75$126KView
May 1, 2026SoldSYRE12,500$71.37$892KView
Apr 1, 2026SoldSYRE6,200$49.21$305KView
Apr 1, 2026SoldSYRE1,300$49.98$65KView
Mar 3, 2026SoldSYRE200$41.66$8KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9205Brian O. Casey
CEO, Westwood Holdings Group. Dallas, TX
$9.4M−$525K (−5.29%)
9206Philip Riley
CFO & EVP STRATEGY, Riley Exploration Permian. Oklahoma City, OK
$9.4M+$34K (+0.37%)
9207Alton Shader
Chief Executive Officer, Sotera Health. Broadview Heights, OH
$9.4M−$41K (−0.43%)
9208Scott L. Burrows
Chief Financial Officer, Spyre Therapeutics. Waltham, MA
$9.4M−$331K (−3.41%)
9209Robert A. Schriesheim
Interim CFO, Skyworks Solutions. Deerfield, IL
$9.4M−$363K (−3.72%)
9210Lisa D. Earnhardt
EVP AND GROUP PRESIDENT, Abbott Laboratories. Abbott Park, IL
$9.4M−$55K (−0.58%)
9211James K. Lee
Chief Operating Officer, Bentley Systems. Exton, PA
$9.4M−$282K (−2.91%)

Other Spyre Therapeutics insiders

All SYRE insiders

Questions

How much stock does Scott L. Burrows own?

Scott L. Burrows holds $9,393,319 in listed stock based on SEC filings and current prices, mostly Spyre Therapeutics (SYRE). That ranks 9208th on the Stock Rich List.

Is this Scott L. Burrows's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Scott L. Burrows last buy or sell stock?

The most recent open-market trade on file is a sale of 600 SYRE shares on Oct 1, 2026 at $89.07.